[Anemia in chronic hemodialysis].
On the basis of general haematological, clinicochemical, cytomorphological, cytochemical and nuclearmedical investigations the anaemia of chronic haemodialysis can be considered as a renal anaemia modified by a permanent dialysis. It is less characterized by lack of erythropoietin, but more by a strong lack of iron, moderate haemolysis and slight deficiency of folic acid. After gradual diagnostics the substitution treatment with iron is absolutely necessary, medication of folic acid should be attempted. A permanent therapy with 80-120 mg of iron weekly administered parenterally can be successfully performed and 10-15 mg of folic acid daily, which will markedly lower the rate of transfusion.
D000740:Anemia / Q000188:drug therapy / Q000209:etiology*; D001803:Blood Transfusion; D002470:Cell Survival; D004920:Erythropoiesis; D005492:Folic Acid / Q000627:therapeutic use; D006801:Humans; D007501:Iron / Q000627:therapeutic use; D006435:Renal Dialysis / Q000009:adverse effects*; D014805:Vitamin B 12 / Q000097:blood
D005492:Folic Acid; D007501:Iron; D014805:Vitamin B 12
Die Anämie bei chronischer Hämodialyse.